Asian patients with type 2 diabetes are generally characterized by defective early phase insulin secretion, DPP-4 inhibitors can improve impaired insulin secretion and then exert greater effects in HbA1c in patients with type 2 diabetes (Xueying and Jingbo, 2016). This evidence concerns the gene DPP4 and type 2 diabetes mellitus.